F5 Networks (NASDAQ: FFIV) reported financial results for its first quarter of 2021.
The company reported revenue of $625 million showing a growth of 10% compared to the previous year.
GAAP net income was recorded at $88 million, compared to the fiscal year 2019 of $99 million.
GAAP earnings per share decreased to $1.41 from $1.62 and non-GAAP earnings per share reported at $2.59 compared to the analyst’s estimate of $2.46.
FFIV stock rose about 1% in the after-market session on Monday.
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings
Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key